Africa has zero access to monkeypox vaccines; US has 60 doses per case reported
The U.S. holds nearly 80% of the Jynneos vaccine used to fight monkeypox, despite having only 35% of the global monkeypox cases, even as many countries go without access to any doses, according to a Public Citizen analysis of public records estimates released today. African countries where monkeypox is endemic, including the Democratic Republic of…